The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?. Fichou, Y., Al-Hilaly, Y. K., Devred, F., Smet-Nocca, C., Tsvetkov, P. O., Verelst, J., Winderickx, J., Geukens, N., Vanmechelen, E., Perrotin, A., Serpell, L., Hanseeuw, B. J., Medina, M., Buée, L., & Landrieu, I. Acta Neuropathologica Communications, 7(1):31, March, 2019.
doi  abstract   bibtex   
Insights into tau molecular structures have advanced significantly in recent years. This field has been the subject of recent breakthroughs, including the first cryo-electron microscopy structures of tau filaments from Alzheimer's and Pick's disease inclusions, as well as the structure of the repeat regions of tau bound to microtubules. Tau structure covers various species as the tau protein itself takes many forms. We will here address a range of studies that help to define the many facets of tau protein structures and how they translate into pathogenic forms. New results shed light on previous data that need now to be revisited in order to up-date our knowledge of tau molecular structure. Finally, we explore how these data can contribute the important medical aspects of this research - diagnosis and therapeutics.
@article{fichou_elusive_2019,
	title = {The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?},
	volume = {7},
	issn = {2051-5960},
	shorttitle = {The elusive tau molecular structures},
	doi = {10.1186/s40478-019-0682-x},
	abstract = {Insights into tau molecular structures have advanced significantly in recent years. This field has been the subject of recent breakthroughs, including the first cryo-electron microscopy structures of tau filaments from Alzheimer's and Pick's disease inclusions, as well as the structure of the repeat regions of tau bound to microtubules. Tau structure covers various species as the tau protein itself takes many forms. We will here address a range of studies that help to define the many facets of tau protein structures and how they translate into pathogenic forms. New results shed light on previous data that need now to be revisited in order to up-date our knowledge of tau molecular structure. Finally, we explore how these data can contribute the important medical aspects of this research - diagnosis and therapeutics.},
	language = {eng},
	number = {1},
	journal = {Acta Neuropathologica Communications},
	author = {Fichou, Yann and Al-Hilaly, Youssra K. and Devred, François and Smet-Nocca, Caroline and Tsvetkov, Philipp O. and Verelst, Joke and Winderickx, Joris and Geukens, Nick and Vanmechelen, Eugeen and Perrotin, Audrey and Serpell, Louise and Hanseeuw, Bernard J. and Medina, Miguel and Buée, Luc and Landrieu, Isabelle},
	month = mar,
	year = {2019},
	pmid = {30823892},
	pmcid = {PMC6397507},
	keywords = {Humans, Brain, tau Proteins, Animals, Tauopathies, Amyloid, Alzheimer’s disease diagnosis, Alzheimer’s disease; tau structure; tau aggregation, Protein Aggregates, Translational Medical Research},
	pages = {31}
}

Downloads: 0